Do analysts prefer CRON or ACB?

Cronos Group presently has a consensus target price of $2.30, indicating a potential downside of 28.90%. Given Cronos Group's stronger consensus rating and higher possible upside, research analysts plainly believe Cronos Group is more favorable than Aurora Cannabis. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cronos Group 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60 Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50

Does the media prefer CRON or ACB?

In the previous week, Cronos Group and Cronos Group both had 3 articles in the media. Cronos Group's average media sentiment score of 0.86 beat Aurora Cannabis' score of -0.81 indicating that Cronos Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cronos Group 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aurora Cannabis 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Negative

Do analysts recommend CGC or CRON?

Cronos Group has a consensus price target of $2.30, suggesting a potential downside of 28.90%. Given Cronos Group's stronger consensus rating and higher probable upside, analysts plainly believe Cronos Group is more favorable than Canopy Growth. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Canopy Growth 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20 Cronos Group 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60

Does the media prefer CGC or CRON?

In the previous week, Canopy Growth had 18 more articles in the media than Cronos Group. MarketBeat recorded 21 mentions for Canopy Growth and 3 mentions for Cronos Group. Canopy Growth's average media sentiment score of 0.93 beat Cronos Group's score of 0.86 indicating that Canopy Growth is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Canopy Growth 14 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cronos Group 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate OGI or CRON?

Cronos Group has a consensus price target of $2.30, indicating a potential downside of 28.90%. Given Cronos Group's higher probable upside, analysts plainly believe Cronos Group is more favorable than Organigram Global. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Organigram Global 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Cronos Group 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60

Does the media prefer OGI or CRON?

In the previous week, Organigram Global and Organigram Global both had 3 articles in the media. Organigram Global's average media sentiment score of 1.16 beat Cronos Group's score of 0.86 indicating that Organigram Global is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Organigram Global 1 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cronos Group 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate CRON or SNDL?

Cronos Group presently has a consensus price target of $2.30, suggesting a potential downside of 28.90%. Given Cronos Group's stronger consensus rating and higher probable upside, research analysts plainly believe Cronos Group is more favorable than SNDL. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cronos Group 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60 SNDL 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Which has stronger valuation & earnings, CRON or SNDL?

Cronos Group has higher earnings, but lower revenue than SNDL. SNDL is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cronos Group $146.59M 8.13 -$9.45M $0.20 16.18 SNDL $677.32M 0.48 -$11.29M -$0.06 N/A

Is CRON or SNDL more profitable?

Cronos Group has a net margin of 39.08% compared to SNDL's net margin of -2.36%. Cronos Group's return on equity of 4.85% beat SNDL's return on equity. Company Net Margins Return on Equity Return on Assets Cronos Group 39.08% 4.85% 4.62% SNDL -2.36% -2.01% -1.67%

Does the media prefer CRON or SNDL?

In the previous week, Cronos Group had 2 more articles in the media than SNDL. MarketBeat recorded 3 mentions for Cronos Group and 1 mentions for SNDL. Cronos Group's average media sentiment score of 0.86 beat SNDL's score of 0.30 indicating that Cronos Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cronos Group 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SNDL 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to TLRY or CRON?

In the previous week, Tilray Brands had 18 more articles in the media than Cronos Group. MarketBeat recorded 21 mentions for Tilray Brands and 3 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.86 beat Tilray Brands' score of 0.40 indicating that Cronos Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tilray Brands 4 Very Positive mention(s) 5 Positive mention(s) 9 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Cronos Group 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Cronos Group (CRON) Competitors

$3.24 +0.03 (+0.78%)

As of 12:07 PM Eastern

Compare

CRON vs. ACB, CGC, OGI, SNDL, and TLRY

Should you buy Cronos Group stock or one of its competitors? Cronos Group's main competitors and comparable companies include Aurora Cannabis (ACB), Canopy Growth (CGC), Organigram Global (OGI), SNDL (SNDL), and Tilray Brands (TLRY). Companies are selected based on similarities in market, industry, and size.

How does Cronos Group compare to Aurora Cannabis?

Cronos Group (NASDAQ:CRON) and Aurora Cannabis (NASDAQ:ACB) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability.

Cronos Group has higher earnings, but lower revenue than Aurora Cannabis. Aurora Cannabis is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	$146.59M	8.13	-$9.45M	$0.20	16.18
Aurora Cannabis	$247.82M	1.04	-$88.13M	-$1.41	N/A

8.7% of Cronos Group shares are owned by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are owned by institutional investors. 7.8% of Cronos Group shares are owned by insiders. Comparatively, 0.0% of Aurora Cannabis shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Cronos Group has a net margin of 39.08% compared to Aurora Cannabis' net margin of -32.26%. Cronos Group's return on equity of 4.85% beat Aurora Cannabis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	39.08%	4.85%	4.62%
Aurora Cannabis	-32.26%	4.37%	3.45%

In the previous week, Cronos Group and Cronos Group both had 3 articles in the media. Cronos Group's average media sentiment score of 0.86 beat Aurora Cannabis' score of -0.81 indicating that Cronos Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cronos Group	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Aurora Cannabis	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Negative

Cronos Group presently has a consensus target price of $2.30, indicating a potential downside of 28.90%. Given Cronos Group's stronger consensus rating and higher possible upside, research analysts plainly believe Cronos Group is more favorable than Aurora Cannabis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Cronos Group has a beta of 0.9, suggesting that its stock price is 10% less volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.63, suggesting that its stock price is 37% less volatile than the broader market.

Summary

Cronos Group beats Aurora Cannabis on 13 of the 16 factors compared between the two stocks.

How does Cronos Group compare to Canopy Growth?

Canopy Growth (NASDAQ:CGC) and Cronos Group (NASDAQ:CRON) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, media sentiment, risk, analyst recommendations, earnings and institutional ownership.

3.3% of Canopy Growth shares are held by institutional investors. Comparatively, 8.7% of Cronos Group shares are held by institutional investors. 0.4% of Canopy Growth shares are held by insiders. Comparatively, 7.8% of Cronos Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Cronos Group has a consensus price target of $2.30, suggesting a potential downside of 28.90%. Given Cronos Group's stronger consensus rating and higher probable upside, analysts plainly believe Cronos Group is more favorable than Canopy Growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Canopy Growth	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
Cronos Group	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60

Cronos Group has lower revenue, but higher earnings than Canopy Growth. Canopy Growth is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Canopy Growth	$251.01M	1.56	-$190.29M	-$0.45	N/A
Cronos Group	$146.59M	8.13	-$9.45M	$0.20	16.18

In the previous week, Canopy Growth had 18 more articles in the media than Cronos Group. MarketBeat recorded 21 mentions for Canopy Growth and 3 mentions for Cronos Group. Canopy Growth's average media sentiment score of 0.93 beat Cronos Group's score of 0.86 indicating that Canopy Growth is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Canopy Growth	14 Very Positive mention(s)	3 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cronos Group	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cronos Group has a net margin of 39.08% compared to Canopy Growth's net margin of -65.33%. Cronos Group's return on equity of 4.85% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Canopy Growth	-65.33%	-21.91%	-14.34%
Cronos Group	39.08%	4.85%	4.62%

Canopy Growth has a beta of 0.78, indicating that its stock price is 22% less volatile than the broader market. Comparatively, Cronos Group has a beta of 0.9, indicating that its stock price is 10% less volatile than the broader market.

Summary

Cronos Group beats Canopy Growth on 13 of the 16 factors compared between the two stocks.

How does Cronos Group compare to Organigram Global?

Organigram Global (NASDAQ:OGI) and Cronos Group (NASDAQ:CRON) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and valuation.

In the previous week, Organigram Global and Organigram Global both had 3 articles in the media. Organigram Global's average media sentiment score of 1.16 beat Cronos Group's score of 0.86 indicating that Organigram Global is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Organigram Global	1 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cronos Group	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cronos Group has a consensus price target of $2.30, indicating a potential downside of 28.90%. Given Cronos Group's higher probable upside, analysts plainly believe Cronos Group is more favorable than Organigram Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Organigram Global	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
Cronos Group	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60

Organigram Global has a beta of 1.5, meaning that its stock price is 50% more volatile than the broader market. Comparatively, Cronos Group has a beta of 0.9, meaning that its stock price is 10% less volatile than the broader market.

34.6% of Organigram Global shares are owned by institutional investors. Comparatively, 8.7% of Cronos Group shares are owned by institutional investors. 0.1% of Organigram Global shares are owned by insiders. Comparatively, 7.8% of Cronos Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Cronos Group has lower revenue, but higher earnings than Organigram Global. Organigram Global is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Organigram Global	$185.07M	0.73	-$17.70M	$0.46	2.09
Cronos Group	$146.59M	8.13	-$9.45M	$0.20	16.18

Cronos Group has a net margin of 39.08% compared to Organigram Global's net margin of 28.14%. Cronos Group's return on equity of 4.85% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Organigram Global	28.14%	-13.39%	-8.67%
Cronos Group	39.08%	4.85%	4.62%

Summary

Cronos Group beats Organigram Global on 9 of the 15 factors compared between the two stocks.

How does Cronos Group compare to SNDL?

Cronos Group (NASDAQ:CRON) and SNDL (NASDAQ:SNDL) are related small-cap companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, media sentiment, institutional ownership, earnings, profitability and dividends.

Cronos Group has a net margin of 39.08% compared to SNDL's net margin of -2.36%. Cronos Group's return on equity of 4.85% beat SNDL's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	39.08%	4.85%	4.62%
SNDL	-2.36%	-2.01%	-1.67%

Cronos Group has higher earnings, but lower revenue than SNDL. SNDL is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	$146.59M	8.13	-$9.45M	$0.20	16.18
SNDL	$677.32M	0.48	-$11.29M	-$0.06	N/A

Cronos Group presently has a consensus price target of $2.30, suggesting a potential downside of 28.90%. Given Cronos Group's stronger consensus rating and higher probable upside, research analysts plainly believe Cronos Group is more favorable than SNDL.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60
SNDL	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

In the previous week, Cronos Group had 2 more articles in the media than SNDL. MarketBeat recorded 3 mentions for Cronos Group and 1 mentions for SNDL. Cronos Group's average media sentiment score of 0.86 beat SNDL's score of 0.30 indicating that Cronos Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cronos Group	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
SNDL	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Cronos Group has a beta of 0.9, suggesting that its share price is 10% less volatile than the broader market. Comparatively, SNDL has a beta of 0.93, suggesting that its share price is 7% less volatile than the broader market.

8.7% of Cronos Group shares are held by institutional investors. 7.8% of Cronos Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Cronos Group beats SNDL on 14 of the 16 factors compared between the two stocks.

How does Cronos Group compare to Tilray Brands?

Tilray Brands (NASDAQ:TLRY) and Cronos Group (NASDAQ:CRON) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, media sentiment, earnings, dividends and risk.

Cronos Group has lower revenue, but higher earnings than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray Brands	$915.45M	0.53	-$121.40M	-$1.08	N/A
Cronos Group	$146.59M	8.13	-$9.45M	$0.20	16.18

Cronos Group has a net margin of 39.08% compared to Tilray Brands' net margin of -13.11%. Cronos Group's return on equity of 4.85% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tilray Brands	-13.11%	-7.76%	-5.59%
Cronos Group	39.08%	4.85%	4.62%

Tilray Brands has a beta of 1.91, meaning that its stock price is 91% more volatile than the broader market. Comparatively, Cronos Group has a beta of 0.9, meaning that its stock price is 10% less volatile than the broader market.

9.4% of Tilray Brands shares are owned by institutional investors. Comparatively, 8.7% of Cronos Group shares are owned by institutional investors. 0.8% of Tilray Brands shares are owned by company insiders. Comparatively, 7.8% of Cronos Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Tilray Brands had 18 more articles in the media than Cronos Group. MarketBeat recorded 21 mentions for Tilray Brands and 3 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.86 beat Tilray Brands' score of 0.40 indicating that Cronos Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tilray Brands	4 Very Positive mention(s)	5 Positive mention(s)	9 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cronos Group	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Tilray Brands currently has a consensus price target of $7.00, indicating a potential upside of 95.26%. Cronos Group has a consensus price target of $2.30, indicating a potential downside of 28.90%. Given Tilray Brands' higher probable upside, equities analysts clearly believe Tilray Brands is more favorable than Cronos Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray Brands	2 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.29
Cronos Group	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60

Summary

Cronos Group beats Tilray Brands on 11 of the 17 factors compared between the two stocks.

Get Cronos Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CRON vs. The Competition

Export

Metric	Cronos Group	Pharmaceuticals Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.19B	$12.22B	$7.12B	$13.24B
Dividend Yield	N/A	2.63%	2.53%	15.88%
P/E Ratio	16.18	799.70	274.21	26.08
Price / Sales	8.13	751.82	607.93	92.41
Price / Cash	263.22	81.79	77.38	51.25
Price / Book	1.08	10.31	10.92	6.30
Net Income	-$9.45M	$2.84B	$3.50B	$361.41M
7 Day Performance	-3.14%	-1.78%	-2.09%	-1.55%
1 Month Performance	-0.15%	-6.04%	-6.33%	-3.80%
1 Year Performance	24.90%	-3.73%	9.10%	2.92%

Cronos Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CRON Cronos Group	1.376 of 5 stars	$3.24 +0.8%	$2.30 -28.9%	+20.7%	$1.19B	$146.59M	16.18	610
ACB Aurora Cannabis	0.9867 of 5 stars	$4.09 -0.2%	N/A	-31.9%	$265.85M	$247.82M	N/A	1,028
CGC Canopy Growth	0.9529 of 5 stars	$0.93 -1.7%	N/A	-36.1%	$423.02M	$251.01M	N/A	1,128
OGI Organigram Global	2.5462 of 5 stars	$1.09 -1.4%	N/A	-48.6%	$155.14M	$185.07M	2.36	1,139	Positive News
SNDL SNDL	0.8033 of 5 stars	$1.39 -0.7%	N/A	-50.4%	$360.36M	$677.32M	N/A	2,751

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CRON) was last updated on 10/2/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cronos Group (CRON) Competitors

CRON vs. ACB, CGC, OGI, SNDL, and TLRY

How does Cronos Group compare to Aurora Cannabis?

Summary

How does Cronos Group compare to Canopy Growth?

Summary

How does Cronos Group compare to Organigram Global?

Summary

How does Cronos Group compare to SNDL?

Summary

How does Cronos Group compare to Tilray Brands?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CRON vs. The Competition

Cronos Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cronos Group (CRON) Competitors

CRON vs. ACB, CGC, OGI, SNDL, and TLRY

How does Cronos Group compare to Aurora Cannabis?

Which has preferable valuation and earnings, CRON or ACB?

Do institutionals and insiders have more ownership in CRON or ACB?

Is CRON or ACB more profitable?

Does the media prefer CRON or ACB?

Do analysts prefer CRON or ACB?

Which has more risk & volatility, CRON or ACB?

Summary

How does Cronos Group compare to Canopy Growth?

Do institutionals & insiders hold more shares of CGC or CRON?

Do analysts recommend CGC or CRON?

Which has higher valuation and earnings, CGC or CRON?

Does the media prefer CGC or CRON?

Is CGC or CRON more profitable?

Which has more volatility and risk, CGC or CRON?

Summary

How does Cronos Group compare to Organigram Global?

Does the media prefer OGI or CRON?

Do analysts rate OGI or CRON?

Which has more volatility and risk, OGI or CRON?

Do insiders and institutionals believe in OGI or CRON?

Which has preferable earnings & valuation, OGI or CRON?

Is OGI or CRON more profitable?

Summary

How does Cronos Group compare to SNDL?

Is CRON or SNDL more profitable?

Which has stronger valuation & earnings, CRON or SNDL?

Do analysts rate CRON or SNDL?

Does the media prefer CRON or SNDL?

Which has more volatility & risk, CRON or SNDL?

Do institutionals & insiders hold more shares of CRON or SNDL?

Summary

How does Cronos Group compare to Tilray Brands?

Which has preferable valuation and earnings, TLRY or CRON?

Is TLRY or CRON more profitable?

Which has more volatility & risk, TLRY or CRON?

Do insiders and institutionals believe in TLRY or CRON?

Does the media refer more to TLRY or CRON?

Do analysts rate TLRY or CRON?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CRON vs. The Competition

Cronos Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools